Employees – Department of Pharmacy

Back to the unit startpage

Employees – Department of Pharmacy

Mikkola, Ingvild

Professor
Department of Pharmacy
FARM F2. 102
+4777646643
Research interests:

The transcriptionfactor Pax6 and its target genes.

CML, Bcr-Abl and resistance.

Zebrafish as a modelsystem.


Holsæter, Ann Mari

Associate professor
Department of Pharmacy
Research interests:

My research interests:

  • Liposomes as drug carriers
  • Hydrogels as drug carriers
  • Liposome-in-gel drug formulations
  • Nanofibers and electrospinning
  • Topical treatment of skinn wounds   
  • Stability testing 
  • Drug-delivery-system optimization (drug entrapment efficiency, particle size, rheological properties, adhesivnes, drug release, safety (animal models), efficiency (in vivo and ex vivo)

 


Hogseth, Rune

Department of Pharmacy
FARM F2. 107
+4777646233

Bø, Karl-Erik

Klinisk farmasi og farmakoepidemiologi, forskningsgruppe

Småbrekke, Lars

Associate professor. Pharmacoepidemiology
Klinisk farmasi og farmakoepidemiologi, forskningsgruppe
FARM f 4.206
+4777645792
Research interests:

Clinical pharmacy and drug consumption on population level, mainly focusing on antibiotics.


Flaten, Gøril Eide

Professor in Drug Transport and Delivery
Department of Pharmacy
Research interests:

The main focus of my research is permeability of drug through and into different absorption
barriers, both in respect of understanding the mechanisms and factors affecting the permeability of compounds, and means to improve the permeability through use of advanced delivery systems. I have, in particular, experience with Advanced nanoparticulate drug delivery systems mainly for poorly soluble drugs as well as use of liposomes as model for cell membranes in interactions with peptides and proteins. My expertise thus spans from development of models for permeability screening as well as estimation of permeability of drugs and drug candidates, formulation of poorly soluble drugs,  characterization of nanoparticulate delivery systems, biopharmaceutical characterisation of delivery systems (cell toxicity and permeability) to in vivo biodistribution studies in mouse models. Administration sites in focus have been the intestine, vagina, and skin, but I have also experience with parenteral formulations for tumour targeted delivery.

 

List of areas of research interests:

  • Permeability through biological barriers (watch movie to learn more).
  • The phospholipid vesicle-based permeation assay (PVPA)
  • Liposomes as drug carriers
  • Liposomes as model systems for cells and bacteria in interaction studies
  • Delivery of lipophilic drug compounds

 

 

 

 

 

 

 

 

 

 

Dissemination to sosiety availeble online

Forskningspodcast fra UiT Norges arktiske universitet (2018)

Hvordan velge de beste kandidatene for fremtidens legemidler? (2018)

42 millioner kroner for utvikling av persontilpasset medisin (2018)

Så lenge holder solkremen din (2017)

Er det sant at man må kaste solkremen etter ett år? (2016)

Skammelig nedprioritering (2016)

Er kvinnesykdommer mindre viktige? (2016)

Skammelig nedprioritering av forskning på kvinnesykdommer (2016)

Finner de beste legemidlene – uten dyreforsøk (2015)

Gjennombrudd: Dyreforsøk med brannskader kan erstattes (2014)

Hermer stoffopptak via hud og tarm (2012)

Legemidler og barrierer (2012)


Skjold, Frode

Senior engineer
Klinisk farmasi og farmakoepidemiologi, forskningsgruppe
FARM F4. 213
+4777646552

1-10 of 90 | Next 10 Last 10